Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
4.080
-0.190 (-4.45%)
At close: Feb 13, 2026, 4:00 PM EST
4.200
+0.120 (2.94%)
After-hours: Feb 13, 2026, 4:18 PM EST
Exicure Market Cap
Exicure has a market cap or net worth of $26.01 million as of February 13, 2026. Its market cap has decreased by -20.25% in one year.
Market Cap
26.01M
Enterprise Value
23.14M
1-Year Change
-20.25%
Ranking
Category
Stock Price
$4.08
Market Cap Chart
Since May 22, 2018, Exicure's market cap has decreased from $122.31M to $26.01M, a decrease of -78.74%. That is a compound annual growth rate of -18.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 27.22M | -21.22% |
| Dec 31, 2025 | 34.55M | -16.84% |
| Dec 31, 2024 | 41.54M | 727.79% |
| Dec 29, 2023 | 5.02M | -12.10% |
| Dec 30, 2022 | 5.71M | -72.06% |
| Dec 31, 2021 | 20.44M | -86.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cue Biopharma | 27.74M |
| Evaxion | 27.73M |
| Lixte Biotechnology Holdings | 27.53M |
| Palatin Technologies | 27.52M |
| Barinthus Biotherapeutics | 26.48M |
| Boundless Bio | 25.85M |
| Rallybio | 25.45M |
| BriaCell Therapeutics | 25.43M |